BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 18339582)

  • 1. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolides and airway inflammation in children.
    Shinkai M; Rubin BK
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M; Henke MO; Rubin BK
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolides in cystic fibrosis.
    McArdle JR; Talwalkar JS
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Why use long-term macrolide therapy in pediatric pulmonology?].
    Corvol H; Taytard J; Thouvenin G; Périsson C; Nathan N; Clement A
    Arch Pediatr; 2014 Mar; 21(3):314-21. PubMed ID: 24503457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
    Fecik RA; Nguyen PL; Venkatraman L
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):741-7. PubMed ID: 16312149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics as biological response modifiers.
    Rubin BK; Tamaoki J
    Curr Opin Investig Drugs; 2000 Oct; 1(2):169-72. PubMed ID: 11249569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S; Egan JJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the immunomodulatory effects of macrolides.
    Tamaoki J; Kadota J; Takizawa H
    Am J Med; 2004 Nov; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Maimon N; Lipton JH; Chan CK; Marras TK
    Bone Marrow Transplant; 2009 Jul; 44(2):69-73. PubMed ID: 19430505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of macrolides: implications for practicing clinicians.
    Siddiqui J
    Am J Med; 2004 Nov; 117 Suppl 9A():26S-29S. PubMed ID: 15586561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V; Bosnar M; Kragol G
    Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
    Majima Y
    Am J Med; 2004 Nov; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of macrolides in lung diseases: recent literature controversies.
    Silva Filho LV; Pinto LA; Stein RT
    J Pediatr (Rio J); 2015; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.